Safety of Intravenous Thrombolysis for Wake-up Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions
Ischemic Stroke
Interventions
DRUG

Alteplase (iv t-PA)

0.9 mg/kg (maximum of 90 mg) IV t-PA will be administered with 10% bolus given over 1 minute, the rest given as an infusion over the remaining hour.

Trial Locations (3)

35233

University of Alabama, Birmingham

77030

UT-Houston Health Science Center, Houston

80113

Swedish Medical Center, Englewood

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

The University of Texas Health Science Center, Houston

OTHER

NCT01183533 - Safety of Intravenous Thrombolysis for Wake-up Stroke | Biotech Hunter | Biotech Hunter